These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 21882931
1. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test. Prokasheva S, Faran Y, Cwikel J, Geffen DB. J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931 [Abstract] [Full Text] [Related]
2. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA. J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545 [Abstract] [Full Text] [Related]
3. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB. J Clin Oncol; 2012 Apr 01; 30(10):1080-6. PubMed ID: 22370315 [Abstract] [Full Text] [Related]
4. Cognitive impairment associated with adjuvant therapy in breast cancer. Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM. Psychooncology; 2006 May 01; 15(5):422-30. PubMed ID: 16097037 [Abstract] [Full Text] [Related]
5. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S. Psychooncology; 2004 Jan 01; 13(1):61-6. PubMed ID: 14745746 [Abstract] [Full Text] [Related]
6. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study. Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S. Psychooncology; 2009 Aug 01; 18(8):811-21. PubMed ID: 19085975 [Abstract] [Full Text] [Related]
7. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U. Patient Educ Couns; 2007 Apr 01; 66(1):108-18. PubMed ID: 17320337 [Abstract] [Full Text] [Related]
8. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Schilder CM, Eggens PC, Seynaeve C, Linn SC, Boogerd W, Gundy CM, Beex LV, Van Dam FS, Schagen SB. Acta Oncol; 2009 Apr 01; 48(1):76-85. PubMed ID: 18777410 [Abstract] [Full Text] [Related]
9. Cognitive deficits in Korean women treated with chemotherapy for breast cancer. Jung MS, Cimprich B. Cancer Nurs; 2014 Apr 01; 37(3):E31-42. PubMed ID: 23945143 [Abstract] [Full Text] [Related]
10. Attention and memory deficits in breast cancer survivors: implications for nursing practice and research. Frank JS, Vance DE, Jukkala A, Meneses KM. J Neurosci Nurs; 2014 Oct 01; 46(5):274-84. PubMed ID: 25099062 [Abstract] [Full Text] [Related]
11. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: a neuropsychological study. Chen X, Zhu C, Li J, Qiu L, Zhang L, Yu F, Ye R, Zhang J, Wang K. Brain Res; 2013 Oct 02; 1533():63-72. PubMed ID: 23954744 [Abstract] [Full Text] [Related]
12. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Collins B, MacKenzie J, Tasca GA, Scherling C, Smith A. Psychooncology; 2013 Jul 02; 22(7):1517-27. PubMed ID: 22936651 [Abstract] [Full Text] [Related]
13. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA. Psychooncology; 2003 Sep 02; 12(6):612-9. PubMed ID: 12923801 [Abstract] [Full Text] [Related]
14. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Kimmick GG, Lovato J, McQuellon R, Robinson E, Muss HB. Breast J; 2006 Sep 02; 12(2):114-22. PubMed ID: 16509835 [Abstract] [Full Text] [Related]
15. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S. Psychooncology; 2009 Feb 02; 18(2):134-43. PubMed ID: 18551510 [Abstract] [Full Text] [Related]
16. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Breast Cancer Res Treat; 2009 Oct 02; 117(3):561-7. PubMed ID: 19153828 [Abstract] [Full Text] [Related]
17. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM. J Clin Oncol; 2002 Jan 15; 20(2):485-93. PubMed ID: 11786578 [Abstract] [Full Text] [Related]
18. Caring for the breast cancer survivor. Abdel-Razeq H. Am J Med; 2011 Feb 15; 124(2):e11; author reply e13. PubMed ID: 21295181 [No Abstract] [Full Text] [Related]
19. Prospective memory impairment in chemotherapy-exposed early breast cancer survivors: Preliminary evidence from a clinical test. Bedard M, Verma S, Collins B, Song X, Paquet L. J Psychosoc Oncol; 2016 Feb 15; 34(4):291-304. PubMed ID: 27123566 [Abstract] [Full Text] [Related]
20. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Partridge AH, Ruddy KJ, Gelber S, Schapira L, Abusief M, Meyer M, Ginsburg E. Fertil Steril; 2010 Jul 15; 94(2):638-44. PubMed ID: 19409543 [Abstract] [Full Text] [Related] Page: [Next] [New Search]